CardioGraph: a Platform to Study Variations Associated with Familiar Cardiopathies

Overview

Journal BMC Med Inform Decis Mak

Publisher Biomed Central

Specialty Medical Informatics

Date 2024 Oct 21

PMID 39434095

Authors

Alberto Garcia S

Mireia Costa

Ana Perez

Oscar Pastor

Affiliations

Soon will be listed here.

Abstract

Background: Familiar cardiopathies are genetic disorders that affect the heart. Cardiologists face a significant problem when treating patients suffering from these disorders: most DNA variations are novel (i.e., they have not been classified before). To facilitate the analysis of novel variations, we present CardioGraph, a platform specially designed to support the analysis of novel variations and help determine whether they are relevant for diagnosis. To do this, CardioGraph identifies and annotates the consequence of variations and provides contextual information regarding which heart structures, pathways, and biological processes are potentially affected by those variations.

Methods: We conducted our work through three steps. First, we define a data model to support the representation of the heterogeneous information. Second, we instantiate this data model to integrate and represent all the genomics knowledge available for familiar cardiopathies. In this step, we consider genomic data sources and the scientific literature. Third, the design and implementation of the CardioGraph platform. A three-tier structure was used: the database, the backend, and the frontend.

Results: Three main results were obtained: the data model, the knowledge base generated with the instantiation of the data model, and the platform itself. The platform code has been included as supplemental material in this manuscript. Besides, an instance is publicly available in the following link: https://genomics-hub.pros.dsic.upv.es:3090 .

Conclusion: CardioGraph is a platform that supports the analysis of novel variations. Future work will expand the body of knowledge about familiar cardiopathies and include new information about hotspots, functional studies, and previously reported variations.

References

Bujak M, Frangogiannis N . The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res. 2006; 74(2):184-95. PMC: 1924687. DOI: 10.1016/j.cardiores.2006.10.002. View

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J . Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5):405-24. PMC: 4544753. DOI: 10.1038/gim.2015.30. View

LeWinter M, Granzier H . Cardiac titin and heart disease. J Cardiovasc Pharmacol. 2013; 63(3):207-12. PMC: 4268868. DOI: 10.1097/FJC.0000000000000007. View

Wang H, Zu Q, Lu M, Chen R, Yang Z, Gao Y . Application of Medical Knowledge Graphs in Cardiology and Cardiovascular Medicine: A Brief Literature Review. Adv Ther. 2022; 39(9):4052-4060. PMC: 9402764. DOI: 10.1007/s12325-022-02254-7. View

Carrier L, Mearini G, Stathopoulou K, Cuello F . Cardiac myosin-binding protein C (MYBPC3) in cardiac pathophysiology. Gene. 2015; 573(2):188-97. PMC: 6660134. DOI: 10.1016/j.gene.2015.09.008. View

Pinero J, Sauch J, Sanz F, Furlong L . The DisGeNET cytoscape app: Exploring and visualizing disease genomics data. Comput Struct Biotechnol J. 2021; 19:2960-2967. PMC: 8163863. DOI: 10.1016/j.csbj.2021.05.015. View

Woodcock E, Matkovich S . Cardiomyocytes structure, function and associated pathologies. Int J Biochem Cell Biol. 2005; 37(9):1746-51. DOI: 10.1016/j.biocel.2005.04.011. View

Campuzano O, Beltran-Alvarez P, Iglesias A, Scornik F, Perez G, Brugada R . Genetics and cardiac channelopathies. Genet Med. 2010; 12(5):260-7. DOI: 10.1097/GIM.0b013e3181d81636. View

Fokkema I, Taschner P, Schaafsma G, Celli J, Laros J, den Dunnen J . LOVD v.2.0: the next generation in gene variant databases. Hum Mutat. 2011; 32(5):557-63. DOI: 10.1002/humu.21438. View

10.

Maron B, Towbin J, Thiene G, Antzelevitch C, Corrado D, Arnett D . Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and.... Circulation. 2006; 113(14):1807-16. DOI: 10.1161/CIRCULATIONAHA.106.174287. View

11.

Kim J . Channelopathies. Korean J Pediatr. 2014; 57(1):1-18. PMC: 3935107. DOI: 10.3345/kjp.2014.57.1.1. View

12.

Choi H, Pavelka N . When one and one gives more than two: challenges and opportunities of integrative omics. Front Genet. 2012; 2:105. PMC: 3262227. DOI: 10.3389/fgene.2011.00105. View

13.

Knoll R, Buyandelger B, Lab M . The sarcomeric Z-disc and Z-discopathies. J Biomed Biotechnol. 2011; 2011:569628. PMC: 3199094. DOI: 10.1155/2011/569628. View

14.

Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M . KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2022; 51(D1):D587-D592. PMC: 9825424. DOI: 10.1093/nar/gkac963. View

15.

Maron B, Maron M, Semsarian C . Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives. J Am Coll Cardiol. 2012; 60(8):705-15. DOI: 10.1016/j.jacc.2012.02.068. View

16.

Yin Z, Ren J, Guo W . Sarcomeric protein isoform transitions in cardiac muscle: a journey to heart failure. Biochim Biophys Acta. 2014; 1852(1):47-52. PMC: 4268308. DOI: 10.1016/j.bbadis.2014.11.003. View

17.

Barriales-Villa R, Gimeno-Blanes J, Zorio-Grima E, Ripoll-Vera T, Evangelista-Masip A, Moya-Mitjans A . Plan of Action for Inherited Cardiovascular Diseases: Synthesis of Recommendations and Action Algorithms. Rev Esp Cardiol (Engl Ed). 2016; 69(3):300-9. DOI: 10.1016/j.rec.2015.11.029. View

18.

Nicora G, Limongelli I, Gambelli P, Memmi M, Malovini A, Mazzanti A . CardioVAI: An automatic implementation of ACMG-AMP variant interpretation guidelines in the diagnosis of cardiovascular diseases. Hum Mutat. 2018; 39(12):1835-1846. DOI: 10.1002/humu.23665. View

19.

McLaren W, Gil L, Hunt S, Riat H, Ritchie G, Thormann A . The Ensembl Variant Effect Predictor. Genome Biol. 2016; 17(1):122. PMC: 4893825. DOI: 10.1186/s13059-016-0974-4. View

20.

Walsh R, Thomson K, Ware J, Funke B, Woodley J, McGuire K . Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet Med. 2016; 19(2):192-203. PMC: 5116235. DOI: 10.1038/gim.2016.90. View